Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma.
Saved in:
| Title: | Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma. |
|---|---|
| Authors: | Born P; Department of Hematology, Hemostaseology and Cellular Therapy University Hospital Leipzig Leipzig Germany., Fandrei D; Department of Hematology, Hemostaseology and Cellular Therapy University Hospital Leipzig Leipzig Germany.; Fraunhofer Institute for Cell Therapy and Immunology IZI Leipzig Germany., Wang SY; Department of Hematology, Hemostaseology and Cellular Therapy University Hospital Leipzig Leipzig Germany., Perez-Fernandez C; Department of Radiology University Hospital Leipzig Leipzig Germany., Fischer L; Department of Hematology, Hemostaseology and Cellular Therapy University Hospital Leipzig Leipzig Germany., Ussmann J; Department of Hematology, Hemostaseology and Cellular Therapy University Hospital Leipzig Leipzig Germany., Bach E; Department of Hematology, Hemostaseology and Cellular Therapy University Hospital Leipzig Leipzig Germany., Hoffmann S; Department of Hematology, Hemostaseology and Cellular Therapy University Hospital Leipzig Leipzig Germany., Metzeler KH; Department of Hematology, Hemostaseology and Cellular Therapy University Hospital Leipzig Leipzig Germany., Herling M; Department of Hematology, Hemostaseology and Cellular Therapy University Hospital Leipzig Leipzig Germany., Herling C; Department of Hematology, Hemostaseology and Cellular Therapy University Hospital Leipzig Leipzig Germany., Jentzsch M; Department of Hematology, Hemostaseology and Cellular Therapy University Hospital Leipzig Leipzig Germany., Boldt A; Department of Clinical Immunology University Hospital Leipzig Leipzig Germany., Seiffert S; Department of Clinical Immunology University Hospital Leipzig Leipzig Germany., Baber R; Institute of Laboratory Medicine, Clinical Chemistry, and Molecular Diagnostics University Hospital Leipzig Leipzig Germany.; Leipzig Medical Biobank Leipzig Germany., Weidner H; Department of Medicine III, Center for Healthy Aging Medical Faculty and University Hospital Carl Gustav Carus Dresden University of Technology Dresden Germany., Franke GN; Department of Hematology, Hemostaseology and Cellular Therapy University Hospital Leipzig Leipzig Germany., Denecke T; Department of Radiology University Hospital Leipzig Leipzig Germany., Sabri O; Department of Nuclear Medicine University Hospital Leipzig Leipzig Germany., Platzbecker U; Department of Hematology, Hemostaseology and Cellular Therapy University Hospital Leipzig Leipzig Germany., Vucinic V; Department of Hematology, Hemostaseology and Cellular Therapy University Hospital Leipzig Leipzig Germany., Meyer HJ; Department of Radiology University Hospital Leipzig Leipzig Germany., Kurch L; Department of Nuclear Medicine University Hospital Leipzig Leipzig Germany., Merz M; Department of Hematology, Hemostaseology and Cellular Therapy University Hospital Leipzig Leipzig Germany.; Myeloma and Cellular Therapy Services Memorial Sloan Kettering Cancer Center New York USA. |
| Source: | HemaSphere [Hemasphere] 2025 Jun 15; Vol. 9 (6), pp. e70159. Date of Electronic Publication: 2025 Jun 15 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2572-9241 |
|---|---|
| DOI: | 10.1002/hem3.70159 |
